This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sampson, L. K. Articles by Phillips, J. O. Search for Related Content PubMed PubMed Citation Articles by Sampson, L. K. Articles by Phillips, J. O.

Tamoxifen-mediated Growth Inhibition of Human Cholangiocarcinoma¹

Department of Surgery [L. K. S., S. M. V.] and Division of Gastroenterology and Hepatology, Department of Medicine [W. Y., J. O. P.], The University of Alabama at Birmingham, Birmingham, Alabama 35294-0007

Cholangiocarcinoma represents a challenging primary malignancy of the liver with no effective medical therapy and a poor prognosis. We have investigated the role of tamoxifen and estrogen receptors (ERs) in the regulation of growth of human cholangiocarcinoma. Two human cholangiocarcinoma cell lines, OZ and SK-ChA-1, were grown in the presence of graded concentrations of tamoxifen; the effects on cell growth were determined by cell counting or 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltet-razolium proliferation assay. The presence of ER protein was tested by indirect immunofluorescence and immunoprecipitation. In addition, cells were grown in estrogen-depleted media supplemented with exogenous 17ß-estradiol. ER mRNA was evaluated by reverse transcription-PCR and Northern blotting. Finally, one cholangiocarcinoma cell line was grown as a xenograft in athymic nude mice; tamoxifen effects on in vivo tumor growth were determined with biweekly caliper measurements. Tamoxifen (5–10 µM) caused dose-dependent in vitro growth inhibition of two human cholangiocarcinoma cell lines. In addition, growth inhibition of one cell line (SK-ChA-1) grown as a xenograft in nude mice by tamoxifen was observed. The presence of ER protein was suggested by 17ß-estradiol stimulation of tumor cell growth in vitro and confirmed by immunoprecipitation. Immunofluorescence microscopy was ineffective at detection of ER protein. Reverse transcription-PCR demonstrated the presence of ER mRNA in both cell lines. Northern blot analysis confirmed the presence of full-length 6.5-kb ER mRNA. No ER deletion mutants were detected. Tamoxifen inhibited the growth of human cholangiocarcinoma in vitro and in vivo. ER protein and mRNA were detected in both cell lines. The mechanism(s) of tamoxifen-mediated growth inhibition is unclear but may occur via ER protein or additional pathways. The ability of tamoxifen to inhibit tumor growth may offer an alternative adjunctive treatment for cholangiocarcinoma.

¹ This research was partially funded by Grant DK 50995 from the NIH and Grant RRG6636 from the NIH Comprehensive Cancer Center.

² To whom requests for reprints should be addressed, at University of Alabama at Birmingham, 405 Kracke Building, 1922 Seventh Avenue, South, Birmingham, AL 35294-0005.

Received 10/15/96. Accepted 3/ 1/97.

This article has been cited by other articles:

				D. Alvaro, B. Barbaro, A. Franchitto, P. Onori, S. S. Glaser, G. Alpini, H. Francis, L. Marucci, P. Sterpetti, S. Ginanni-Corradini, et al. Estrogens and Insulin-Like Growth Factor 1 Modulate Neoplastic Cell Growth in Human Cholangiocarcinoma Am. J. Pathol., September 1, 2006; 169(3): 877 - 888. [Abstract] [Full Text] [PDF]

				G. Alpini, N. Kanno, J. L. Phinizy, S. Glaser, H. Francis, S. Taffetani, and G. LeSage Tauroursodeoxycholate inhibits human cholangiocarcinoma growth via Ca2+-, PKC-, and MAPK-dependent pathways Am J Physiol Gastrointest Liver Physiol, June 1, 2004; 286(6): G973 - G982. [Abstract] [Full Text] [PDF]

				E.-Y. Ahn, G. Pan, J. H. Oh, E. M. Tytler, and J. M. McDonald The Combination of Calmodulin Antagonists and Interferon-{gamma} Induces Apoptosis through Caspase-Dependent and -Independent Pathways in Cholangiocarcinoma Cells Am. J. Pathol., November 1, 2003; 163(5): 2053 - 2063. [Abstract] [Full Text] [PDF]

				G. Pan, S. M. Vickers, A. Pickens, J. O. Phillips, W. Ying, J. A. Thompson, G. P. Siegal, and J. M. McDonald Apoptosis and Tumorigenesis in Human Cholangiocarcinoma Cells : Involvement of Fas/APO-1 (CD95) and Calmodulin Am. J. Pathol., July 1, 1999; 155(1): 193 - 203. [Abstract] [Full Text] [PDF]